Relmada Therapeutics Inc. (RLMD)

[VictorMasonIsRight]

Relmada Scientific advisors for Phase 2 at Harvard

Maurizio Fava
https://www.massgeneral.org/doctors/doctor.aspx?id=16784
Dr. Maurizio Fava is director, Division of Clinical Research of the Massachusetts General Hospital (MGH) Research Institute, executive vice chair of the Department of Psychiatry and executive director of the Clinical Trials Network and Institute, (MGH),
http://mgh-ctni.org/
and associate dean for clinical and translational research and the Slater Family Professor of Psychiatry at Harvard Medical School.


Paolo Manfredi
Dr. Paolo Manfredi is board certified in Neurology and Psychiatry, in Pain Medicine and in Hospice and Palliative Care. He has completed fellowships at MD Anderson Cancer Center and Massachusetts General Hospital, where he obtained the Golden Needle Award. He has served as the Director of Pain Management and Palliative Care Program
https://www.jpsmjournal.com/article/S0885-3924(00)00163-9/abstract at Mount Sinai Medical Center where he was Assistant Professor in Neurology, Anesthesia and Geriatric Medicine.

Charles Inturrisi
Charles E. Inturrisi, PhD, is professor of pharmacology, Weill Medical College of Cornell University; professor, Programs in Pharmacology and Neuroscience, Weill Graduate School of Medical Sciences of Cornell University;
https://gradschool.weill.cornell.edu/faculty/charles-inturrisi
and visiting investigator, Pain and Palliative Care Service, Memorial Sloan-Kettering Cancer Center.


Michael E. Thase, MD
Dr. Michael E. Thase joined the faculty of the Perelman School of Medicine at the University of Pennsylvania in 2007 as Professor of Psychiatry after more than 27 years at the University of Pittsburgh Medical Center and the Western Psychiatric Institute and Clinic.
http://www.med.upenn.edu/apps/faculty/index.php/g332/p8144704